Alpha Centric Advisors LLC Iovance Biotherapeutics, Inc. Transaction History

Alpha Centric Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$9.53 - $13.11 $190,600 - $262,200	-20,000 Closed	0 $0
Q4 2021 Feb 25, 2022	SELL	$16.55 - $27.63 $173,775 - $290,115	-10,500 Reduced 34.43%	20,000 $382,000
Q3 2021 Mar 09, 2022	SELL	$20.35 - $26.63 $61,050 - $79,890	-3,000 Reduced 8.96%	30,500 $752,000
Q2 2021 Mar 09, 2022	BUY	$16.33 - $33.07 $498,064 - $1.01 Million	30,500 Added 1016.67%	33,500 $872,000
Q1 2021 Mar 09, 2022	BUY	$28.67 - $52.59 $28,670 - $52,590	1,000 Added 50.0%	3,000 $95,000
Q4 2020 Mar 11, 2022	BUY	$28.04 - $50.26 $23,834 - $42,721	850 Added 73.91%	2,000 $93,000
Q2 2020 Mar 11, 2022	BUY	$27.21 - $41.0 $31,291 - $47,150	1,150 New	1,150 $32,000

316

244M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $898M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.